Tag

Lowe Archives - Carey Danis & Lowe

Boston Scientific Mesh Damages Cut from $100 Million to $10 Million

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Boston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsBoston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsA judge in the ongoing mesh litigation against Boston Scientific significantly reduced the amount awarded to a victim in a May jury trial.

New Castle County, Delaware Judge Mary Johnston said the compensations awarded to Deborah Barba ($100 million) – the biggest ever in a trial involving transvaginal mesh – were “grossly disproportionate to the injuries.” Other transvaginal mesh trials have awarded between 1.75 million to 7.76 million in damages.

While the lawyers see this compensation reduction as a disappointment, they’re encouraged that the judge didn’t question the jury’s finding on Boston Scientific’s liability. Judge Johnston denied Boston Scientific’s attempt to set aside the verdict completely and order a new trial.

The mesh devices caused Deborah Barba severe complications, including bladder infections and pelvic pain. The jury found that the device manufacturer had been negligent in designing the transvaginal mesh and didn’t warn doctors and patients about the risks.

Boston Scientific, along with other mesh makers have faced about 100,000 lawsuits at the state and federal level for transvaginal mesh complications.

Carey Danis and Lowe can help victims of transvaginal mesh complications.

If you or women you know have been harmed by mesh devices, call our medical product liability lawyers for a free consultation at 800-721-2519. Alternatively, send us an email.

Our team of medical professionals will answer your questions with compassion and confidentiality. Our attorneys can help you get the justice you deserve.

NuvaRing Lawsuit Dismissal is a Betrayal

By | Defective Medical Device litigation, NuvaRing, Uncategorized

nuvaring_lawsuit_heart_attackErika Langhart’s family feels betrayed by the legal system. The Langharts brought a lawsuit against Merck because they believe Merck’s product NuvaRing caused their daughter’s death. Their case was dismissed, denying the couple, through a jury trial, the chance to warn other women of the drug’s life-threatening complications.

A San Francisco Superior Court dismissed the case against Merck and Company on Sept. 10, 2015. The case centered on the NuvaRing medical device, a type of hormonal birth control.

Erika Langhart had 2 heart attacks in 2011 and died on Thanksgiving day. Her parents maintain that Erika died from complications caused by NuvaRing’s desogestrel, a progestin used in the drug.

A New York law firm promised the Langharts a jury trial to broadcast their grievances against the company. Now however, there’s no chance to openly hold Merck accountable because the court dismissed the case.

A Diabolical Legal and Regulatory System

Karen Langhart, Erika’s mother, feels utterly betrayed by the legal and regulatory systems that are in place to protect people.

The Langharts were trying to safeguard and warn other young women about the dangers of NuvaRing. Stripped of the jury trial process, they’ve created a nonprofit foundation to make their voices heard. “Informed Choice for AmErika”, named for their daughter, encourages young women to research all aspects of birth control drugs before making a decision.

Nothing can be done to bring back their cherished daughter, but the Langharts continue to help women change their lives by getting informed about NuvaRing hazards.

Carey Danis and Lowe can help NuvaRing victims.

If you or someone you know has suffered from using NuvaRing, please give our product liability lawyers a call at 800.721.2519. You may be entitled to compensation for your suffering.

Our expert medical device attorneys will guide you through a free consultation. Please email us to set up an appointment today.

Bard Will Pay $200 Million to Resolve 3000 Vaginal-Mesh Cases

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

trans_vaginal_mesh_complications_recall_fda_erosion_lawsuit_settlementsAnother victory has been scored for vaginal mesh sufferers. CR Bard said that it will pay out $200 million to settle 3000 cases. This pay out represents about 20 percent of remaining lawsuits against mesh device makers.

Bard was forced into this decision because US District Judge Joseph Goodwin warned that more multimillion dollar jury verdicts might push the company into bankruptcy. Since Bard lost several jury cases in regular proceedings and on appeal, the judge saw that it wasn’t likely that Bard would win upcoming cases.

In order to prepare for future victim compensation, Bard, based in Murray Hill, New Jersey, added $337 million to its $660 million reserve for medical device-liability cases.

The company is discussing settlements with attorneys for other victims who blame Bard’s vaginal mesh for their injuries, which include crippling pain and the inability to walk.

Carey Danis & Lowe Can Help

Have you suffered from vaginal mesh? Carey Danis and Lowe attorneys specialize in mesh defect cases. Our firm provides free legal evaluations—please tell us about your case if you’ve been harmed by transvaginal mesh products.

Our on-staff medical experts are ready to answer your questions about complications from faulty mesh devices. Call us at 800-721-2519 to schedule a private consultation. We’ll guide you through your legal options and potential compensation eligibility.

Iowa Newspaper Reports on Transvaginal Mesh Side Effects

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

transvaginal_mesh_mdl_2013_settlements_side_effects_court_filing_lawsuitsOne woman’s transvaginal mesh story has become the subject of an article published in The Gazette, a newspaper based in Cedar Rapids, Iowa. Frances Shulte, who was interviewed by the Iowa publication, underwent surgery to receive an implant of transvaginal mesh in 2005 to treat stress urinary incontinence (SUI).

Her personal experience involving an incredible amount of pain and suffering is similar to that of thousands of other women who also received an implant of transvaginal mesh.

According to The Gazette, Shulte’s transvaginal mesh eroded, which is an all too common defect of certain types of mesh products. When transvaginal mesh begins to erode inside of the body, it can cause damage to internal organs and severe pain during any kind of movement.

In an effort to raise awareness of life-altering side effects, such as transvaginal mesh erosion, and to prevent future implants of defective mesh, Shulte has filed a lawsuit against the manufacturer of the product that she used.

A West Virginia federal court is currently managing seven transvaginal mesh multidistrict litigations (MDLs). Thousands of lawsuits have been consolidated into this West Virginia federal court targeted at Johnson & Johnson and Ethicon, C.R. Bard, American Medical Systems, Cook Medical, Boston Scientific, Coloplast, and Neomedic, the latter being the latest medical device manufacturer to be added to the transvaginal mesh MDL roster.

As a national law firm providing legal representation to victims of defective medical devices, Carey Danis & Lowe is familiar with Shulte’s transvaginal mesh story. Our team of transvaginal mesh lawyers encourages you to begin exploring your legal options and compensation eligibility today.

If, like Shulte, you would like to ensure that women are no longer injured by defective transvaginal mesh, Carey Danis & Lowe is available now to listen to your own transvaginal mesh story, and to guide you through the process of filing a transvaginal mesh lawsuit against your mesh manufacturer.

Rumored Dismissal of First Ethicon MDL Bellwether Case

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

ethicon johson johnsonThe first transvaginal mesh lawsuit in the Ethicon multidistrict litigation (MDL) in a West Virginia federal court has reportedly discontinued proceedings following a ruling for dismissal handed down by the court.

The plaintiff in the case, Carolyn Lewis, filed her transvaginal mesh lawsuit against Johnson & Johnson and Ethicon after sustaining injuries that she believes were caused by a product manufactured by Ethicon that provides structural support to failing pelvic muscles. Lewis claims that the Ethicon device was poorly designed, and resulted in her sustaining serious internal injuries.

In a number of cases involving defective transvaginal mesh, certain devices prove to be incompatible for long-term internal use, and they begin to shrink, harden, and erode, all while still implanted in the patient. Transvaginal mesh erosion is one of the most commonly reported adverse events, and causes serious injuries to the patient, including organ damage.

As expressed in the Bloomberg article, it has still not yet been verified with the court if the Lewis case has in fact been rejected, an outcome that would relieve Johnson & Johnson and Ethicon of responsibility for the plaintiff’s injuries.

The transvaginal mesh attorneys at Carey Danis & Lowe are eager to see the impact that this first bellwether case has on the remaining bellwether cases in the Ethicon MDL. Carey Danis & Lowe is a plaintiff’s litigation law firm headquartered in St. Louis, with additional offices across the country. Our team of litigators represents victims of defective medical devices, among them transvaginal mesh products.

Though the first bellwether case has reportedly been rejected, such an outcome should not discourage anyone who believes that they have been injured by a transvaginal mesh product from seeking legal assistance. Carey Danis & Lowe encourages you to begin exploring your legal options and your eligibility for compensation today in a free initial consultation.

Our lawyers are available now to hear your transvaginal mesh story. Call us at 800.721.2519, or complete a confidential personal injury claim form.

J&J and Ethicon to Pay Penalty for Document Mishandling

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Boston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsBoston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsJohnson & Johnson and Ethicon mishandled internal documents that were of great importance in the Ethicon multidistrict litigation (MDL) being heard in West Virginia. As a result, U.S. Magistrate Judge Cheryl Eifert penalized Johnson & Johnson, and their subsidiary, Ethicon, by ordering them to pay a fine.

The court is still deciding on the penalty amount.

It is unclear if Johnson & Johnson and Ethicon, the medical device manufacturer behind the Gynecare Prolift transvaginal mesh product, purposefully destroyed the internal documents in question. Since purposeful destruction was never proven, Johnson & Johnson and Ethicon were not dealt more severe penalties.

There are over 16,000 transvaginal mesh lawsuits pending in the Ethicon MDL in West Virginia. The Ethicon MDL is In re: Ethicon, Inc. Pelvic Repair Systems Product Liability Litigation MDL no. 2327, and is being heard in the U.S. District Court for the Southern District of West Virginia.

Victims of transvaginal mesh, including those who received an implant of the Ethicon Gynecare Prolift, have contacted Carey Danis & Lowe for legal assistance. The team of class action attorneys at Carey Danis & Lowe currently represents many women across the United States in transvaginal mesh lawsuits.

Explore your legal options and eligibility for compensation with Carey Danis & Lowe today. Schedule an appointment to meet with one of our attorneys in person at one of our four locations. We have law offices in Missouri, Illinois, and Florida.

Our attorneys are also available to discuss your case over the phone. Contact our law offices by calling 800.721.2519.

You can also contact us by completing a personal injury claim form.

UK Doctors Warn Patients of Yasmin & Yaz Side Effects

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_yasmin_side_effects_lawsuits_dvt_blood_clot_settlementsAn article recently published by UK news organization the Daily Mail describes the country’s increased efforts in requiring physicians to adequately warn patients of the risks of using certain kinds of oral contraceptives. The article specifically mentions the oral contraceptive drug, Yasmin, which is manufactured by Bayer, the pharmaceutical company behind Yaz.

Health officials in the UK announced their new initiative amid reports that newer types of oral contraceptives place women at two times the risk of developing blood clots.

Both Yasmin and Yaz contain a newer type of synthetic hormone, what is called a third-generation progestin. A number of these third-generation progestins have been linked to an increased risk in the development of blood clots. Drospirenone, the type of progestin present in both Yasmin and Yaz, as well as generic counterpart Ocella, is just such a progestin that has been linked through numerous studies to a higher risk of venous thromboembolism.

The personal injury and defective drug lawyers at Carey Danis & Lowe are encouraged to see health officials in the United Kingdom act on the serious threats posed by Yasmin and Yaz to patient health and safety.

Carey Danis & Lowe represents victims of Yasmin and Yaz across the United States. If you believe that you have been injured by Yasmin or Yaz, we welcome you to begin exploring your legal options and eligibility for compensation today with a Carey Danis & Lowe attorney. Our initial case evaluations are free.

Carey Danis & Lowe is available to listen to your story today. Share with us how Yasmin or Yaz has impacted your health and quality of life. Contact Carey Danis & Lowe by phone at 800.721.2519, or complete one of our confidential personal injury claim forms.

NuvaRing User Suffered Life-Altering Blood Clots

By | Defective Medical Device litigation, NuvaRing, Uncategorized

nuvaringThe Huffington Post recently published an article in which the author describes her experience using the NuvaRing contraceptive device. Writing for the Huffington Post, Nancy Polanco describes using the NuvaRing for less than two months before landing in the emergency room.

Polanco’s NuvaRing nightmare began when she was having difficulty exercising. Later, she struggled to breathe to such as degree that she had to go to the emergency room, where doctors discovered that she had dangerously low oxygen levels. The reason for her breathing troubles and low oxygen levels were the result of her use of the NuvaRing.

Polanco had developed blood clots in her lungs, a condition known as a pulmonary embolism.

Now, Polanco, along with many other women who have used this contraceptive device, believes that NuvaRing’s manufacturer, Merck, failed to make users aware of the contraceptive device’s life-threatening and life-altering side effects.

In addition to the formation of blood clots, patients who use the NuvaRing have an increased risk of heart attack and stroke.

This increased risk of blood clot formation, heart attack, and stroke are due to the newer kind of hormone used in the NuvaRing, a third-generation progestin known as etonogestrel. As documented in numerous epidemiological studies, etonogestrel has a strong connection to blood clot formation.

The St. Louis class action attorneys at Carey Danis & Lowe represent victims of defective drugs and medical devices. We are currently providing legal counsel to a number of women who claim to have been injured by the NuvaRing contraceptive device. If you believe that you have been harmed by the NuvaRing, Carey Danis & Lowe encourages you to explore your legal options with one of our NuvaRing lawyers today. Our initial consultations are free.

If you are concerned about the impacts that the NuvaRing has on patient health and safety, in particular NuvaRing and blood clots, Carey Danis & Lowe works alongside a team of medical professionals. Our nurses and medical experts are available to answer your health questions.

Share your NuvaRing story with Carey Danis & Lowe today. Contact us by phone at 800.721.2519, or complete a confidential personal injury claim form.

Follow the Carey Danis & Lowe blog to stay up-to-date on the latest NuvaRing lawsuit news.

Australian Women Considering Yaz Class Action Lawsuit

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_bayer_multidistrict_litigation_yaz_settlements_yaz_yasmin_lawsuit_settlementsHundreds of women in Australia are considering filing a class action lawsuit targeted at Bayer, the pharmaceutical company behind the contraceptive pills Yaz and Yasmin. The latest reports estimate that the class action lawsuit could involve 600 women.

As cited in the article from Australia’s 7 News, the British Medical Journal published studies, including one from 2011, whose data demonstrated a three fold increased risk of blood clots in women using Yaz, Yasmin, and Ocella, the generic equivalent of Yaz, in comparison to those women using other kinds of contraceptive drugs.

Many of the women who are considering filing a Yaz lawsuit against Bayer have experienced serious side effects, some of which became so serious, hospitalization was necessary. One such victim, an Australian woman interviewed for the 7 News article, experienced a stroke that she believes is the result of having used Yaz.

The woman is considering legal action for the purposes of discontinuing the manufacture of drugs like Yaz, Yasmin, and Ocella. An additional motivating factor is to prevent other women from experiencing a Yaz related stroke.

The St. Louis class action attorneys at Carey Danis & Lowe represent individuals in lawsuits filed across the United States who have been negatively affected by defective drugs. We work diligently for our clients to win them the day in court they they so rightfully deserve. Contact our experienced trial lawyers today to explore your legal options and compensation eligibility if you believe that you have sustained a serious injury as the result of using either Yaz, Yasmin, or Ocella.

Carey Danis & Lowe is ready to work with you. Share your Yaz, Yasmin, or Ocella story with us today. Contact Carey Danis & Lowe by phone at 800.721.2519, or complete a confidential personal injury claim form.

Two Ethicon MDL Bellwether Cases Rescheduled

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Boston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsBoston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsThe latest news relating to transvaginal mesh lawsuits involves a new court document filed in a federal court in West Virginia. The court document relates to the rescheduling of forthcoming bellwether trials in the Ethicon multidistrict litigation (MDL).

Two cases selected for the bellwether process, Dianne M. Bellew v. Ethicon and Brenda Lehrer v. Ethicon, were scheduled to begin in August 2014.

However, U.S. District Judge Joseph R. Goodwin has rescheduled the cases to be heard starting December 2014.

The court document did not disclose the reasons for rescheduling these two bellwether cases.

The Ethicon MDL is In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation MDL no. 2327, and is being heard in the U.S. District Court for the Southern District of West Virginia, Charleston Division.

The lawsuits consolidated into the Ethicon MDL charge medical device manufacturer, Ethicon, a subsidiary of Johnson & Johnson, with producing defective transvaginal mesh products that victims allege have caused serious injuries. One of the most common transvaginal mesh side effects is mesh erosion, wherein the product hardens and erodes inside of the body resulting in organ damage.

Carey Danis & Lowe is a national law firm that is currently representing victims of transvaginal mesh. For those who believe that their injuries are the result of defective transvaginal mesh, contact one of our medical device lawyers at Carey Danis & Lowe to explore your legal options in a free and confidential case evaluation.